Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis
Evidence level: retrospective human tissue study; abstract-only
A histopathology study reporting pleuroparenchymal fibroelastosis as a major tissue correlate of restrictive allograft syndrome.
As of . Primary source: Publisher record via DOI.
Summary
This retrospective study reviewed 493 patients who underwent lung transplantation between 1996 and mid-2009. Of 47 patients with clinical features of restrictive allograft syndrome (RAS), 16 had lung tissue available from wedge biopsy, retransplant explant or autopsy. According to the abstract, all 16 showed pleural fibrosis and 15 showed parenchymal fibroelastosis, mostly beneath the pleura. Features of obliterative bronchiolitis were present in 14 cases, and diffuse alveolar damage in 13 cases, usually in specimens taken less than one year after clinical onset. The authors conclude that pleuroparenchymal fibroelastosis is a major histopathologic correlate of RAS and that the findings support diffuse alveolar damage followed by pleuroparenchymal fibroelastosis in the evolution of RAS. The study design is retrospective and the numbers are small.
Details
- doi
- 10.1038/modpathol.2012.171
- pmid
- 23018877
- authors
- Ofek E, Sato M, Saito T, Wagnetz U, Roberts HC, Chaparro C, Waddell TK, Singer LG, Hutcheon MA, Keshavjee S, Hwang DM
- journal
- Modern Pathology
- year
- 2013
- volume
- 26
- issue
- 3
- pages
- 350-356
Sources and links
- Publisher record via DOI (primary)
- PubMed 23018877
Related
Links from this record
- describes tissue findings of: Restrictive allograft syndrome (RAS)
- builds on: Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunction
Known gaps in this record
- full text not read (abstract only)
- funding statement and grant numbers
- author affiliations
- centre or centres not stated in the abstract
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.